Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS II)
- 30 September 2003
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 146 (3) , 484-488
- https://doi.org/10.1016/s0002-8703(03)00312-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarctionThe Lancet, 2001
- Fibrinolysis for Acute Myocardial InfarctionCirculation, 2001
- Polyethylene Glycol–Derivatized Cysteine-Substitution Variants of Recombinant Staphylokinase for Single-Bolus Treatment of Acute Myocardial InfarctionCirculation, 2000
- 1999 Update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and RecommendationsCirculation, 1999
- TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial InfarctionCirculation, 1998
- Staphylokinase: a potent, uniquely fibrin-selective thrombolytic agentNature Medicine, 1998
- Randomized Comparison of Coronary Thrombolysis Achieved With Double-Bolus Reteplase (Recombinant Plasminogen Activator) and Front-Loaded, Accelerated Alteplase (Recombinant Tissue Plasminogen Activator) in Patients With Acute Myocardial InfarctionCirculation, 1996
- TIMI Frame CountCirculation, 1996
- More Rapid, Complete, and Stable Coronary Thrombolysis With Bolus Administration of Reteplase Compared With Alteplase Infusion in Acute Myocardial InfarctionCirculation, 1995
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987